CD38 targeting in multiple myeloma

被引:0
|
作者
Abel, Andrea [1 ]
Cano, Laia Querol [1 ]
van Spriel, Annemiek [1 ]
Hammink, Roel [1 ]
ter Beest, Martin [1 ]
机构
[1] Radboud Inst Mol Life Sci RIMLS, Nijmegen, Netherlands
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-377
引用
收藏
页码:S248 / S248
页数:1
相关论文
共 50 条
  • [21] CD38 expression by plasma cells in extramedullary multiple myeloma
    Notarfranchi, Laura
    Accardi, Fabrizio
    Mancini, Cristina
    Martella, Eugenia
    Bonomini, Sabrina
    Segreto, Roberta
    Vescovini, Rosanna
    Palma, Anna Benedetta Dalla
    Sammarelli, Gabriella
    Todaro, Giannalisa
    Storti, Paola
    Burroughs-Garcia, Jessica
    Iannozzi, Nicolas Thomas
    Raimondi, Vincenzo
    Lungu, Oxana
    Ricci, Stefania
    Craviotto, Luisa
    Giuliani, Nicola
    HAEMATOLOGICA, 2024, 109 (04) : 1297 - 1300
  • [22] Anti CD38 monoclonal antibodies for multiple myeloma treatment
    Gozzetti, Alessandro
    Ciofini, Sara
    Simoncelli, Martina
    Santoni, Adele
    Pacelli, Paola
    Raspadori, Donatella
    Bocchia, Monica
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [23] CD38 Expression Loss in Multiple Myeloma Treated with Daratumumab
    Hotchandani, Nihar
    Fung, Henry
    Dulaimi, Essel
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [24] CD38 Monoclonal Antibodies in Relapsed/Refractory Multiple Myeloma
    Verina, Daniel
    Fowler, Amanda
    Louw, Karen
    Barnes, Yvonne
    Vickroy, Angela
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (07): : 693 - 698
  • [25] CD38 expression by plasma cells in extramedullary multiple myeloma
    Notarfranchi, Laura
    Accardi, Fabrizio
    Mancini, Cristina
    Martella, Eugenia
    Bonomini, Sabrina
    Segreto, Roberta
    Vescovini, Rosanna
    Dalla Palma, Anna Benedetta
    Sammarelli, Gabriella
    Todaro, Giannalisa
    Storti, Paola
    Burroughs-Garcia, Jessica
    Iannozzi, Nicolas Thomas
    Raimondi, Vincenzo
    Lungu, Oxana
    Ricci, Stefania
    Craviotto, Luisa
    Giuliani, Nicola
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1297 - 1300
  • [26] Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma
    Ise, Mikiko
    Matsubayashi, Keiko
    Tsujimura, Hideki
    Kumagai, Kyoya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (05): : E59 - E64
  • [27] Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Reverse Immunosuppression in Multiple Myeloma
    Feng, Xiaoyan
    Acharya, Chirag
    An, Gang
    Wen, Kenneth
    Zhang, Li
    Kalbasi, Alireza
    Qiu, Lugui
    Munshi, Nikhil C.
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    BLOOD, 2016, 128 (22)
  • [28] Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma
    Feng, Xiaoyan
    Zhang, Li
    Acharya, Chirag
    An, Gang
    Wen, Kenneth
    Qiu, Lugui
    Munshi, Nikhil C.
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4290 - 4300
  • [29] Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma
    van de Donk, Niels W. C. J.
    Moreau, Philippe
    Plesner, Torben
    Palumbo, Antonio
    Gay, Francesca
    Laubach, Jacob P.
    Malavasi, Fabio
    Avet-Loiseau, Herve
    Mateos, Maria-Victoria
    Sonneveld, Pieter
    Lokhorst, Henk M.
    Richardson, Paul G.
    BLOOD, 2016, 127 (06) : 681 - 695
  • [30] Targeting CD38 and CD138 Antigens through NK Cell Immunotherapy for Effective Treatment of Multiple Myeloma
    Lee, Seung-Hwan
    Jo, Dong-Hyeon
    Kaczmarek, Shelby
    Ghaziasgar, Safa
    Shin, Oksu
    Shin, Joy
    Cowan, Juthaporn
    Mccomb, Scott
    Visram, Alissa
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):